| Summary of Net Revenue Cost of Sales, Operating Profit, Depreciation and Amortization, Interest Expense, Income Tax Benefit (Expense), Other Comprehensive Income, and Assets by Segment |
The following table shows, by segment: net revenue, cost of sales,
operating profit, depreciation and amortization, interest expense,
income tax benefit (expense), other comprehensive income, and
assets for the years ended November 30, 2016 and 2015:
|
|
|
|
|
|
|
|
|
| |
|
For the years ended November 30, |
|
| |
|
2016 |
|
|
2015 |
|
|
Net revenue:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
22,777,919 |
|
|
$ |
20,620,138 |
|
|
PrepaCyte CB
|
|
|
350,128 |
|
|
|
471,293 |
|
|
|
|
|
|
|
|
|
|
|
Total net revenue
|
|
$ |
23,128,047 |
|
|
$ |
21,091,431 |
|
|
|
|
|
|
|
|
|
|
|
Cost of sales:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
5,446,126 |
|
|
$ |
5,276,125 |
|
|
PrepaCyte CB
|
|
|
328,674 |
|
|
|
354,740 |
|
|
|
|
|
|
|
|
|
|
|
Total cost of sales
|
|
$ |
5,774,800 |
|
|
$ |
5,630,865 |
|
|
|
|
|
|
|
|
|
|
|
Operating profit:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
2,447,160 |
|
|
$ |
2,842,957 |
|
|
PrepaCyte CB
|
|
|
(2,013,566 |
) |
|
|
90,267 |
|
|
|
|
|
|
|
|
|
|
|
Total operating profit
|
|
$ |
433,594 |
|
|
$ |
2,933,224 |
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
240,916 |
|
|
$ |
218,568 |
|
|
PrepaCyte CB
|
|
|
45,735 |
|
|
|
22,640 |
|
|
|
|
|
|
|
|
|
|
|
Total depreciation and amortization
|
|
$ |
286,651 |
|
|
$ |
241,208 |
|
|
|
|
|
|
|
|
|
|
|
Interest expense:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
925,075 |
|
|
$ |
1,277,815 |
|
|
PrepaCyte CB
|
|
|
22,265 |
|
|
|
26,057 |
|
|
|
|
|
|
|
|
|
|
|
Total interest expense
|
|
$ |
947,340 |
|
|
$ |
1,303,872 |
|
|
|
|
|
|
|
|
|
|
|
Income tax benefit (expense):
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
1,141,823 |
|
|
$ |
7,166,789 |
|
|
PrepaCyte CB
|
|
|
17,589 |
|
|
|
(9,967 |
) |
|
|
|
|
|
|
|
|
|
|
Total income tax benefit (expense)
|
|
$ |
1,159,412 |
|
|
$ |
7,156,822 |
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive (loss) income:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
(135,524 |
) |
|
$ |
169,932 |
|
|
PrepaCyte CB
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive (loss) income
|
|
$ |
(135,524 |
) |
|
$ |
169,932 |
|
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
18,960,261 |
|
|
$ |
16,697,621 |
|
|
PrepaCyte CB
|
|
|
578,207 |
|
|
|
2,800,325 |
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
19,538,468 |
|
|
$ |
19,497,946 |
|
|
|
|
|
|
|
|
|
|
|